(SNY) Sanofi - Performance 16.9% in 12m
Compare SNY with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
39.58%
#30 in Group
Rel. Strength
74.91%
#2005 in Universe
Total Return 12m
16.89%
#40 in Group
Total Return 5y
27.74%
#45 in Group
P/E 21.4
54th Percentile in Group
P/E Forward 11.3
38th Percentile in Group
PEG 0.91
44th Percentile in Group
FCF Yield 4.95%
69th Percentile in Group
12m Total Return: SNY (16.9%) vs XLV (-0.5%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: SNY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for SNY
Total Return (including Dividends) | SNY | XLV | S&P 500 |
---|---|---|---|
1 Month | -13.89% | -7.37% | -5.89% |
3 Months | -1.53% | -4.55% | -12.45% |
12 Months | 16.89% | -0.54% | 6.72% |
5 Years | 27.74% | 46.59% | 101.06% |
Trend Score (consistency of price movement) | SNY | XLV | S&P 500 |
1 Month | -87.8% | -82.6% | -74.5% |
3 Months | 7.10% | -37.8% | -88.2% |
12 Months | 39.3% | -1.6% | 66.1% |
5 Years | 68.7% | 90.1% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #108 | -7.04% | -8.50% |
3 Month | #43 | 3.17% | 12.5% |
12 Month | #40 | 17.5% | 9.53% |
5 Years | #46 | -12.9% | -36.5% |
FAQs
Does SNY Sanofi outperforms the market?
Yes,
over the last 12 months SNY made 16.89%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months SNY made -1.53%, while XLV made -4.55%.
Over the last 3 months SNY made -1.53%, while XLV made -4.55%.
Performance Comparison SNY vs Indeces and Sectors
SNY vs. Indices SNY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 0.24% | -8.0% | 2.04% | 10.2% |
US NASDAQ 100 | QQQ | 1.10% | -7.61% | 2.57% | 11.4% |
US Dow Jones Industrial 30 | DIA | 1.41% | -8.07% | 1.50% | 11.6% |
German DAX 40 | DAX | -5.12% | -4.49% | -15.0% | -1.32% |
Shanghai Shenzhen CSI 300 | CSI 300 | -0.47% | -6.39% | -0.24% | 11.0% |
Hongkong Hang Seng | HSI | -4.05% | -4.07% | 0.52% | 0.67% |
India NIFTY 50 | INDA | -4.13% | -18.7% | -0.41% | 13.8% |
Brasil Bovespa | EWZ | -3.32% | -8.81% | -0.91% | 26.4% |
SNY vs. Sectors SNY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.01% | -8.23% | -6.77% | 3.35% |
Consumer Discretionary | XLY | 1.11% | -9.97% | -0.70% | 7.67% |
Consumer Staples | XLP | -3.06% | -17.1% | -8.18% | 2.95% |
Energy | XLE | -4.48% | -3.81% | 0.98% | 27.2% |
Financial | XLF | -1.13% | -9.38% | -6.08% | -2.06% |
Health Care | XLV | -0.16% | -6.52% | 3.44% | 17.4% |
Industrial | XLI | -0.88% | -9.19% | 1.96% | 11.5% |
Materials | XLB | -1.48% | -7.24% | 9.12% | 24.4% |
Real Estate | XLRE | -5.10% | -11.0% | 0.69% | -0.22% |
Technology | XLK | 1.60% | -4.96% | 8.85% | 18.1% |
Utilities | XLU | -3.07% | -13.5% | -3.70% | -7.48% |
Aerospace & Defense | XAR | -1.45% | -13.9% | -7.72% | -7.27% |
Biotech | XBI | -3.32% | -2.01% | 16.6% | 25.8% |
Homebuilder | XHB | -0.71% | -7.05% | 19.9% | 26.0% |
Retail | XRT | -1.46% | -11.8% | 6.71% | 21.3% |